Sodium Hyaluronate
Recently Published Documents


TOTAL DOCUMENTS

1073
(FIVE YEARS 326)

H-INDEX

56
(FIVE YEARS 12)

Life ◽  
2021 ◽  
Vol 11 (9) ◽  
pp. 992
Author(s):  
Raffaella Belvedere ◽  
Nunzia Novizio ◽  
Daniela Eletto ◽  
Amalia Porta ◽  
Antonino Bagnulo ◽  
...  

Epistaxis is one of the most frequent hemorrhages resulting from local or systemic factors. Its management without hospitalization has prompted an interest in locally applied hemostatic agents. Generally, the therapy approaches involve sprays or creams acting as a physical barrier, even used as tampons or gauze. In this study, we have investigated the activity of Emoxilane®, a combination of sodium hyaluronate, silver salt, α-tocopherol acetate and D-panthenol, which is known to be able to separately act in a different biological manner. Our in vitro results, obtained on endothelial and nasal epithelial cells, have shown that the association of these molecules presented a notable antioxidant activity mainly due to the α-tocopherol and D-panthenol and a significant antimicrobial role thanks to the silver compound. Moreover, remarkable hemostatic activity was found by evaluating plasmin inhibition attributable to the sodium hyaluronate. Interestingly, on human plasma, we have confirmed that Emoxilane® strongly induced the increase of thrombin levels. These data suggest that the use of this association could represent an appealing pharmacological approach to actively induce hemostasis during epistaxis. Our future perspective will aim to the creation of a formulation for an easy topical application in the nose which is able to contrast the bleeding.


Author(s):  
Kwang-Il Lee ◽  
Tae-Hoon Koo ◽  
Peter Chen ◽  
Darryl D. D’Lima
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document